Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Caitlin E. Cox

October 08, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

Todd Neale

August 12, 2024

News Daily News

FDA Medical Devices Chief Jeff Shuren Announces Retirement

L.A. McKeown

July 24, 2024

News Daily News

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

L.A. McKeown

July 24, 2024

News Daily News

Dietary Salt Linked to AF Risk in Patients With Vascular Disease or Diabetes

L.A. McKeown

July 11, 2024

News Daily News

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

Todd Neale

June 27, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Daily News

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Caitlin E. Cox

March 01, 2024

News Daily News

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Yael L. Maxwell

February 15, 2024

Advertisement

Top Endovascular News of 2024

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Scientific Statement Reviews Current Antithrombotic Options in PAD

Platelet Hyperreactivity Score May Improve CVD Risk Detection

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

FDA Medical Devices Chief Jeff Shuren Announces Retirement

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

Dietary Salt Linked to AF Risk in Patients With Vascular Disease or Diabetes

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

FDA Approves Bioresorbable Scaffold for BTK Lesions

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content